SCHEMBL13426438

SCHEMBL13426438

C[Si](C)(C)c1c2ccc(N3CCCc4ccccc43)cc2c([Si](C)(C)C)c2ccc(N3CCCc4ccccc43)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.48
NUDT1 P36639 1/20 0.43
ROCK1 Q13464 1/20 0.42
ALDH1A1 P00352 6/20 0.40
MAPT P10636 5/20 0.40
RAB9A P51151 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 2/20 0.40
TP53 P04637 2/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
AKT1 P31749 1/20 0.40
PIK3CA P42336 1/20 0.40
KIT P10721 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
OPRM1 P35372 1/20 0.39
JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426440 0.84 EED (0.42) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13426436 0.82 EED (0.48) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL15306247 0.81 OPRM1 (0.45) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13615882 0.81 OPRM1 (0.45) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL16522065 0.80 EED (0.44) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13428095 0.80 MEN1 (0.33) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL13615777 0.79 OPRM1 (0.44) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13615962 0.79 OPRM1 (0.44) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13615919 0.79 OPRM1 (0.44) EEDNUDT1ROCK1ALDH1A1MAPT
SCHEMBL13426439 0.78 EED (0.43) EEDNUDT1ROCK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A EED 1151/4885NUDT1 655/4885ROCK1 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.